Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Literature
1.
Querol L, Crabtree M, Herepath M, Priedane E, Viejo Viejo I, Agush S et al (2020) Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol
2.
Kapoor M, Spillane J, Englezou C, Sarri-Gonzalez S, Bell R, Rossor A et al (2020) Thromboembolic risk with IVIg: incidence and risk factors in patients with inflammatory neuropathy. Neurology 94(6):e635–e638CrossRef
3.
Abbas A, Rajabally YA (2019) Complications of immunoglobulin therapy and implications for treatment of inflammatory neuropathy: a review. Curr Drug Saf 14(1):3–13CrossRef
4.
(2009) Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study. Lancet Neurol 8(2):158–64
5.
Mahdi-Rogers M, van Doorn PA, Hughes RA (2013) Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev (6):CD003280
6.
Oaklander AL, Lunn MP, Hughes RA, van Schaik IN, Frost C, Chalk CH (2017) Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database Syst Rev 1(1):Cd010369PubMed
7.
Rajabally YA, Afzal S (2019) Clinical and economic comparison of an individualised immunoglobulin protocol vs standard dosing for chronic inflammatory demyelinating polyneuropathy. J Neurol 266(2):461–467CrossRef
8.
Mengel D, Fraune L, Sommer N, Stettner M, Reese JP, Dams J et al (2018) Costs of illness in chronic inflammatory demyelinating polyneuropathy in Germany. Muscle Nerv 58(5):681–687CrossRef
9.
Rajabally YA, Seow H, Wilson P (2006) Dose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathy. J Peripheral Nerv Syst JPNS. 11(4):325–329CrossRef
10.
Lunn MP, Ellis L, Hadden RD, Rajabally YA, Winer JB, Reilly MM (2016) A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies. J Periph Nerv Syst JPNS 21(1):33–37CrossRef
Metadata
Title
Burden of illness in chronic inflammatory demyelinating polyneuropathy: some facts and solutions
Author
Yusuf A. Rajabally
Publication date
01-10-2020
Publisher
Springer Berlin Heidelberg
Keyword
Polyneuropathy
Published in
Journal of Neurology / Issue 10/2020
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-020-10101-4

Other articles of this Issue 10/2020

Journal of Neurology 10/2020 Go to the issue

Letter to the Editors

Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence?

Original Communication

Newly developed stroke in patients admitted to non-neurological intensive care units

Correction

Correction to: CT angiography vs echocardiography for detection of cardiac thrombi in ischemic stroke: a systematic review and meta-analysis

Original Communication

Mechanical thrombectomy for ischaemic stroke in the anterior circulation: off-hours effect

Original Communication

Nationwide survey of 780 Japanese patients with amyotrophic lateral sclerosis: their status and expectations from brain–machine interfaces

Original Communication

Factors associated with employment and expected work retention among persons with multiple sclerosis: findings of a cross-sectional citizen science study